Harrow (HROW) Total Current Liabilities (2010 - 2026)
Harrow (HROW) posted quarterly Total Current Liabilities of $91.4 million for Q1 2026, down 51.1% year-over-year from $187.0 million in Q1 2025, and down 5.05% quarter-over-quarter from $96.3 million in Q4 2025.
Harrow (HROW) Total Current Liabilities (2010 - 2026) Analysis & Trends
Harrow's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $91.4 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 51.1% year-over-year to $91.4 million; the TTM figure through Mar 2026 stood at $91.4 million (down 51.1% YoY), while the FY2025 annual figure was $96.3 million, up 5.43% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $91.4 million, down from $96.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $248.9 million in Q2 2025, with the low at $9.2 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $49.3 million (2023), against an average of $67.0 million.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities surged 399.26% in 2024, then slumped 51.1% in 2026.
- Harrow's Total Current Liabilities stood at $18.6 million in 2022, then surged by 164.83% to $49.3 million in 2023, then surged by 85.11% to $91.3 million in 2024, then climbed by 5.43% to $96.3 million in 2025, then retreated by 5.05% to $91.4 million in 2026.
- Business Quant data shows HROW's Total Current Liabilities at $91.4 million in Q1 2026, $96.3 million in Q4 2025, and $65.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Harrow | 1.55 Bn | 1.47 Bn | 50.36 Mn | 102.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 102.17 Mn |
| Mar 31, 2026 | 91.44 Mn |
| Dec 31, 2025 | 96.30 Mn |
| Sep 30, 2025 | 65.40 Mn |
| Jun 30, 2025 | 248.88 Mn |
| Mar 31, 2025 | 186.99 Mn |
| Dec 31, 2024 | 91.34 Mn |
| Sep 30, 2024 | 95.01 Mn |
| Jun 30, 2024 | 53.55 Mn |
| Mar 31, 2024 | 41.75 Mn |
| Dec 31, 2023 | 49.34 Mn |
| Sep 30, 2023 | 19.03 Mn |
| Jun 30, 2023 | 23.01 Mn |
| Mar 31, 2023 | 17.71 Mn |
| Dec 31, 2022 | 18.63 Mn |
| Sep 30, 2022 | 18.37 Mn |
| Jun 30, 2022 | 12.92 Mn |
| Mar 31, 2022 | 9.18 Mn |
| Dec 31, 2021 | 9.72 Mn |
| Sep 30, 2021 | 10.48 Mn |